Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer
Anna‐Lena Scherr(Heidelberg University), Bruno Köhler(Heidelberg University)
Cited by 39
Related Papers
Specific Targeting of Antiapoptotic Bcl-2 Proteins as a Radiosensitizing Approach in Solid Tumors
|International Journal of Molecular Sciences|2022|14
<scp>Bcl‐x<sub>L</sub></scp> as prognostic marker and potential therapeutic target in cholangiocarcinoma
|Liver International|2022|8